RxDoctor Payments Data

Andrew Courson, MD

Otolaryngology/Facial Plastic Surgery · Kingwood, TXNPI 1992023097

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.

$7,105in general payments, 2019–2025

Across 172 payments — averaging $41.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Aerin Medical Inc.$1K
  • GSK$724
  • Optinose US, Inc.$619
  • Regeneron Healthcare Solutions, Inc.$406
  • Sanofi$401
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$7,105100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,105 in reported general payments places this provider in the 80th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.

See all otolaryngology/facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$159,949
Medicare patients
445
Services billed
1,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide216$6,273
Azelastine Hcl128$2,697
Fluocinolone Acetonide Oil54$2,344
Fluticasone Propionate122$1,588
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,425
Mometasone Furoate15$986
Methylprednisolone149$966
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav88$825
Mupirocin64$790
Clindamycin Hcl49$467
Levocetirizine Dihydrochloride35$384
Ciprofloxacin Hcl37$359
Montelukast Sodium21$283
Levofloxacin35$224
Cephalexin17$140

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Kingwood

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →